Found: 3
Select item for more details and to access through your institution.
Phase 2 Open-Label Study of Bortezomib, Cladribine, and Rituximab in Advanced, Newly Diagnosed, and Relapsed/Refractory Mantle-Cell and Indolent Lymphomas.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study.
- Published in:
- Oncology, 2018, v. 94, n. 5, p. 274, doi. 10.1159/000486788
- By:
- Publication type:
- Article
A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma.
- Published in:
- Oncology, 2017, v. 93, n. 6, p. 401, doi. 10.1159/000479230
- By:
- Publication type:
- Article